Mechanism of action (MOA)1

The MOA of VRAYLAR is unknown. The efficacy of VRAYLAR is thought to be mediated through a combination of the following activities:

Receptor Activity
Central dopamine D2 Partial agonist
Serotonin 5–HT1A Partial agonist
Serotonin 5–HT2A Antagonist

Pharmacodynamics1

VRAYLAR receptor-binding affinity